Pfizer – CD33 Positive Acute Myelogenous Leukemia

Access Program Information

An expanded access/compassionate use protocol that allows access to Mylotarg for
relapsed/refractory AML CD33 positive patients in the USA.

Contact: [email protected]

Rare Disease: